E-Book, Englisch, Band 110/1, 256 Seiten, eBook
Vol 1: Pathophysiology
E-Book, Englisch, Band 110/1, 256 Seiten, eBook
Reihe: Acta Neurochirurgica Supplement
ISBN: 978-3-7091-0353-1
Verlag: Springer Wien
Format: PDF
Kopierschutz: Wasserzeichen (»Systemvoraussetzungen)
Zielgruppe
Research
Autoren/Hrsg.
Weitere Infos & Material
1;Preface;6
2;Acknowledgement;8
3;Contents;10
4;Part I: Advances in Subarachnoid Hemorrhage and Cerebral Vasospasm;14
4.1;Section I: Honored Guest & Honored Speaker Speeches;15
4.1.1;A Clinical Review of Cerebral Vasospasm and Delayed Ischaemia Following Aneurysm Rupture;16
4.1.2;New Regulatory, Signaling Pathways, and Sources of Nitric Oxide;18
4.2;Section II: Advances in Subarachnoid Hemorrhage Research;24
4.2.1;Advances in Experimental Subarachnoid Hemorrhage;25
4.2.2;Advances in Treatment of Cerebral Vasospasm: an Update;32
4.2.3;Roles of Signal Transduction Mechanisms in Cerebral Vasospasm Following Subarachnoid Hemorrhage: Overview;36
5;Part II: Mechanistic Studies;40
5.1;Section III: Early Brain Injury After Subarachnoid Hemorrhage;41
5.1.1;Hypoperfusion in the Acute Phase of Subarachnoid Hemorrhage;42
5.1.2;Association of APOE Polymorphism with the Change of Brain Function in the Early Stage of Aneurysmal Subarachnoid Hemorrhage;46
5.1.3;Apoptotic Mechanisms for Neuronal Cells in Early Brain Injury After Subarachnoid Hemorrhage;50
5.1.4;Early Micro Vascular Changes After Subarachnoid Hemorrhage;56
5.1.5;Immunological Response in Early Brain Injury After SAH;63
5.1.6;Mechanisms of Early Brain Injury After SAH: Matrixmetalloproteinase 9;68
5.1.7;Tyrosine Phosphatase Inhibition Attenuates Early Brain Injury After Subarachnoid Hemorrhage in Rats;71
5.1.8;Protection of Minocycline on Early Brain Injury After Subarachnoid Hemorrhage in Rats;75
5.1.9;Role of Osteopontin in Early Brain Injury After Subarachnoid Hemorrhage in Rats;79
5.1.10;Matrix Metalloproteinase 9 Inhibition Reduces Early Brain Injury in Cortex After Subarachnoid Hemorrhage;84
5.2;Section IV: Nitric Oxide & Cortical Spreading Depolarization After Subarachnoid Hemorrhage;88
5.2.1;Nitric Oxide Synthase Inhibitors and Cerebral Vasospasm;89
5.2.2;The Role of Nitric Oxide Donors in Treating Cerebral Vasospasm After Subarachnoid Hemorrhage;94
5.2.3;Nitric Oxide in Early Brain Injury After Subarachnoid Hemorrhage;99
5.2.4;Nitric Oxide Related Pathophysiological Changes Following Subarachnoid Haemorrhage;104
5.2.5;Endothelin-1(1–31) Induces Spreading Depolarization in Rats;109
5.2.6;The Gamut of Blood Flow Responses Coupled to Spreading Depolarization in Rat and Human Brain: from Hyperemia to Prolonged Ischemia;116
5.2.7;Cerebral Microdialysis in Acutely Brain-Injured Patients with Spreading Depolarizations;122
5.3;Section V: Pathophysiology of Cerebral Vasospasm;128
5.3.1;Mitogen-Activated Protein Kinases in Cerebral Vasospasm After Subarachnoid Hemorrhage: A Review;129
5.3.2;Association of Apolipoprotein E Polymorphisms with Cerebral Vasospasm After Spontaneous Subarachnoid Hemorrhage;136
5.3.3;Impact of Subarachnoid Hemorrhage on Local and Global Calcium Signaling in Cerebral Artery Myocytes;140
5.3.4;Enhanced Angiogenesis and Astrocyte Activation by Ecdysterone Treatment in a Focal Cerebral Ischemia Rat Model;146
5.3.5;Bilirubin Oxidation Products Seen Post Subarachnoid Hemorrhage Have Greater Effects on Aged Rat Brain Compared to Young;151
5.3.6;Preliminary Results of an ICP-Controlled Subarachnoid Hemorrhage Rabbit Model for the Study of Delayed Cerebral Vasospasm;157
5.3.7;PKGIa Inhibits the Proliferation of Cerebral Arterial Smooth Muscle Cell Induced by Oxyhemoglobin After Subarachnoid Hemorrhage;160
5.3.8;Characteristics of In Vivo Animal Models of Delayed Cerebral Vasospasm;165
5.3.9;Endothelin Related Pathophysiology in Cerebral Vasospasm: What Happens to the Cerebral Vessels?;168
5.3.10;Expression and Role of COMT in a Rat Subarachnoid Hemorrhage Model;172
5.4;Section VI: Clinical Manifestations of Subarachnoid Hemorrhage;179
5.4.1;Monitoring of the Inflammatory Response After Aneurysmal Subarachnoid Haemorrhage in the Clinical Setting: Review of Literature and Report of Preliminary Clinical Experience;180
5.4.2;Perimesencephalic Subarachnoid Hemorrhage: Risk Factors, Clinical Presentations, and Outcome;186
5.4.3;The Relationship Between IL-6 in CSF and Occurrence of Vasospasm After Subarachnoid Hemorrhage;191
5.4.4;Non-Aneurysm Subarachnoid Hemorrhage in Young Adults;197
5.4.5;Cardiac Damage After Subarachnoid Hemorrhage;202
5.4.6;Analysis on Death-Associated Factors of Patients with Subarachnoid Hemorrhage During Hospitalization;206
5.4.7;Clinical Study of Changes of Cerebral Microcirculation in Cerebral Vasospasm After SAH;211
5.4.8;Effect of Weekend Admission on in-Hospital Mortality After Subarachnoid Hemorrhage in Chongqing China;215
5.4.9;The Correlation Between COMT Gene Polymorphism and Early Cerebral Vasospasm After Subarachnoid Hemorrhage;219
5.4.10;Fever Increased In-Hospital Mortality After Subarachnoid Hemorrhage;225
5.4.11;Subarachnoid Hemorrhage in Old Patients in Chongqing China;230
6;Author Index;234
7;Subject Index;236
8;Table of Contents for Vol. 1;242
9;Table of Contents for Vol. 2;246